Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy ImmunoPrecise Antibodies stock (ImmunoPrecise Antibodies)

Buy ImmunoPrecise Antibodies stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

ImmunoPrecise Antibodies is a biotechnology business based in the US. ImmunoPrecise Antibodies shares (IPA) are listed on the NASDAQ and all prices are listed in US Dollars. ImmunoPrecise Antibodies employs 102 staff and has a trailing 12-month revenue of around $23.7 million.

Our top picks for where to buy Immunoprecise Antibodies stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy ImmunoPrecise Antibodies stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – IPA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy ImmunoPrecise Antibodies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

ImmunoPrecise Antibodies stock price (NASDAQ: IPA)

Use our graph to track the performance of IPA stocks over time.

ImmunoPrecise Antibodies shares at a glance

Information last updated 2024-07-07.
Latest market close$0.98
52-week range$0.94 - $3.05
50-day moving average $1.12
200-day moving average $1.47
Wall St. target price$7.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Is it a good time to buy ImmunoPrecise Antibodies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ImmunoPrecise Antibodies price performance over time

Historical closes compared with the close of $0.98 from 2024-07-10

1 week (2024-07-05) -2.00%
1 month (2024-06-12) -6.67%
3 months (2024-04-12) -27.94%
6 months (2024-01-12) -40.96%
1 year (2023-07-12) -67.22%
2 years (2022-07-12) -76.16%
3 years (2021-07-12) 5.36
5 years (2019-07-12) 96.00%

ImmunoPrecise Antibodies financials

Revenue TTM $23.7 million
Gross profit TTM $11.6 million
Return on assets TTM -10.99%
Return on equity TTM -25.72%
Profit margin -60.22%
Book value $1.89
Market Capitalization $26.3 million

TTM: trailing 12 months

ImmunoPrecise Antibodies share dividends

We're not expecting ImmunoPrecise Antibodies to pay a dividend over the next 12 months.

You may also wish to consider:

Have ImmunoPrecise Antibodies's shares ever split?

ImmunoPrecise Antibodies's shares were split on a 1:5 basis on 22 November 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ImmunoPrecise Antibodies shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for ImmunoPrecise Antibodies shares which in turn could have impacted ImmunoPrecise Antibodies's share price.

ImmunoPrecise Antibodies share price volatility

Over the last 12 months, ImmunoPrecise Antibodies's shares have ranged in value from as little as $0.94 up to $3.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ImmunoPrecise Antibodies's is 0.261. This would suggest that ImmunoPrecise Antibodies's shares are less volatile than average (for this exchange).

To put ImmunoPrecise Antibodies's beta into context you can compare it against those of similar companies.

ImmunoPrecise Antibodies overview

ImmunoPrecise Antibodies Ltd. , together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes.

Frequently asked questions

What percentage of ImmunoPrecise Antibodies is owned by insiders or institutions?
Currently 13.592% of ImmunoPrecise Antibodies shares are held by insiders and 6.392% by institutions.
How many people work for ImmunoPrecise Antibodies?
Latest data suggests 102 work at ImmunoPrecise Antibodies.
When does the fiscal year end for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies's fiscal year ends in April.
Where is ImmunoPrecise Antibodies based?
ImmunoPrecise Antibodies's address is: 3204?4464 Markham Street, Victoria, BC, Canada, V8Z 7X8
What is ImmunoPrecise Antibodies's ISIN number?
ImmunoPrecise Antibodies's international securities identification number is: CA45257F2008

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site